GHK-Cu Before and After: Realistic Results, Timeline, and What the Evidence Shows

15 min readWritten by Protocol Health Editorial TeamMedically reviewed by Richard Dentico, MDPublished Updated

A realistic GHK-Cu before and after is a modest change in skin over months, not a transformation in weeks. Lab and animal data are strong, human skin data are small and mixed, and published controlled data on injections are missing. This guide ties every time point to a named study and shows how to read a before-and-after photo.

GHK-Cu Before and After: Realistic Results, Timeline, and What the Evidence Shows
Here’s what we’ll cover

Key takeaways

  • GHK-Cu works in cells. It raised collagen production in cultured fibroblasts (Maquart et al., 1988).
  • The blinded human trial was null on objective measures. After laser resurfacing, evaluators found no significant difference at 12 weeks (Miller et al., 2006).
  • Topical has more human evidence than injection. Support comes from small cosmetic studies (Pickart et al., 2015).
  • Injectable GHK-Cu is FDA-flagged. The FDA cites limited human safety data and immunogenicity risk (FDA).

Short Answer

GHK-Cu Before and After: What Can You Realistically Expect?

A realistic GHK-Cu before and after is a modest change in skin texture or fine lines over several months, not a transformation in a few weeks, and most of the evidence behind it comes from skin care applied to the skin, not from injections. GHK-Cu is a three-amino-acid peptide bound to copper. It is found in human plasma, saliva and urine, and its levels decline with age (Pickart, 2015).

The laboratory case is real. GHK-Cu raised collagen production in cultured fibroblasts, the cells that build skin's support structure (Maquart, 1988), and it increased collagen and other connective tissue in experimental wounds in rats (Maquart, 1993). Those findings explain the interest. They do not tell you what you will see in the mirror.

Human results are smaller and mixed. In a randomized trial after carbon dioxide laser resurfacing, which 13 patients completed, blinded evaluators found no significant difference in wrinkles or overall skin quality between a GHK-Cu skin regimen and a regimen without it, while patients using GHK-Cu rated their skin quality higher (Miller, 2006). That gap between how skin is rated by the person and by a blinded observer is the central problem with before-and-after photos.

If you are weighing GHK-Cu, start with our copper peptides guide and our short assessment.

So the honest GHK-Cu before and after is a slow, modest change at best, supported mainly by topical skin studies and laboratory work.

How Long

How Long Does GHK-Cu Take to Work?

No published human trial has tracked how long GHK-Cu takes to work week by week, so the precise week-by-week schedules found online are estimates, not trial findings. What the studies offer instead is a handful of fixed time points.

The human laser-resurfacing trial judged wrinkles and overall skin appearance at 12 weeks, and by then patients in both groups had improved significantly, with no objective difference between them (Miller, 2006). In animals, effects on wounds showed up within days: in rats with ischemic skin wounds, topical GHK-Cu gel shrank wound area by 64.5% by day 13, compared with 45.6% for the gel base alone and 28.2% with no treatment (Canapp, 2003). Wound healing is not wrinkle repair, though, and a rat wound is not aging human skin.

A useful yardstick is retinol, one of the best-studied topical anti-aging ingredients. Its randomized, vehicle-controlled trial on the arm skin of 36 older adults ran 24 weeks before reporting a significant improvement in fine wrinkles (Kafi, 2007). Skin remodeling is slow, so a claim of dramatic change within days is hard to square with how collagen is rebuilt.

In practice, judge any skin change over about three months or more, with photos taken the same way each time, and treat faster claims with suspicion.

Timeline

What Does a GHK-Cu Timeline Look Like in Studies?

A GHK-Cu timeline built from studies, rather than from marketing, has only a few points on it, and most of them come from animals. The table lists each measured time point and the study it comes from.

Time pointWho or what was studiedWhat was foundSource
Days 3 to 1324 rats in 3 groups (copper-peptide gel, gel base, no treatment), ischemic woundsFaster wound closure than no treatment; 64.5% smaller wound area by day 13Canapp, Vet Surg 2003
Days 7 to 2118 rabbits in 3 groups (copper complex daily, zinc oxide, no treatment), open woundsSmaller unhealed wound area than no treatment at days 7, 14 and 21Cangul, Vet Dermatol 2006
12 weeks13 people who completed, randomized to skin care with or without GHK-Cu, after CO2 laser resurfacingBoth groups improved; no blinded difference in wrinkles or skin quality; higher patient-rated skin quality with GHK-CuMiller, Arch Facial Plast Surg 2006
24 weeks (comparison, not GHK-Cu)36 older adults, 0.4% retinol lotion vs vehicle on arm skinSignificant improvement in fine wrinklesKafi, Arch Dermatol 2007
Any time pointInjected GHK-Cu in peopleNo published controlled human data identified; FDA cites limited human dataFDA bulk substances list
Animal wound data are not skin-aging data. Sources: Canapp 2003; Cangul 2006; Miller 2006; Kafi 2007; FDA.

The rabbit study applied the copper complex daily for 21 days and found the unhealed wound area significantly smaller than in untreated rabbits at every check (Cangul, 2006). For injections, the FDA states there are limited data in humans to inform safety (FDA).

Bottom line: the evidence-based GHK-Cu timeline is days for animal wounds and about 12 weeks for a blinded human skin trial, and that trial found no objective difference.

Skin

GHK-Cu Before and After for Skin: What Do Studies Show?

GHK-Cu before and after skin results are best supported for topical products, where reviews report firmer, more elastic skin and fewer fine lines, but that evidence rests on small cosmetic studies. A 2015 review reports that in cosmetic products GHK-Cu tightened loose skin, improved elasticity, density and firmness, and reduced fine lines, wrinkles, photodamage and hyperpigmentation, and a 2008 review describes controlled studies on aged skin with similar findings.

These reviews, like the 2018 review cited in this article, come from researchers at Skin Biology, a company that sells copper peptide skin care, which is worth weighing alongside their conclusions.

The cell work is consistent with a skin effect. In cultured human fibroblasts, including fibroblasts from skin treated with radiation therapy, GHK-Cu sped up cell growth, and the irradiated cells made more basic fibroblast growth factor and vascular endothelial growth factor soon after exposure (Pollard, 2005).

The strongest human test, the blinded laser trial, is where the gap shows. Every patient's wrinkles and skin quality improved after resurfacing, but the GHK-Cu group did no better on objective measures, even though those patients were more satisfied (Miller, 2006). A before-and-after photo from either group would have looked like a success.

So GHK-Cu before and after skin photos may reflect a real but modest topical effect, other treatments, or simply time, and the studies cannot yet separate them cleanly.

Hair

What Does GHK-Cu Before and After Look Like for Hair?

GHK-Cu before and after hair results have the thinnest support of any claimed use: the evidence we could verify is laboratory work, not controlled human trials of regrowth, apart from one small 2026 eyebrow study (18 people, GHK-Cu form undefined) that does not address scalp regrowth.

The most cited hair study used a related copper peptide, AHK-Cu, not GHK-Cu. In it, AHK-Cu lengthened human hair follicles kept alive outside the body and increased the growth of dermal papilla cells, the cells that drive the hair follicle (Pyo, 2007). A 2008 review also lists larger hair follicle size and better hair transplant success among GHK-Cu's effects, again from the same company-affiliated authors.

Hair thinning has many medical causes, including hormone changes, thyroid disease and low iron, so a GHK-Cu before and after hair photo says little unless the cause was diagnosed first. Our guide to peptides for skin and hair compares the hair evidence across peptides. For an option with controlled hair trials, see PRP for hair loss.

So a GHK-Cu hair before and after is, for now, a hypothesis built on follicle and cell studies, not a documented human result.

Injections

What Do GHK-Cu Injection Results Show?

GHK-Cu injection results in people have not been shown in a published controlled trial that we could find, and the FDA states that there are limited data in humans to inform safety (FDA). Most GHK-Cu peptide injection before and after images online are personal photos, not study results.

The animal injection data are narrower than they sound. In the 1993 rat study, GHK-Cu was injected into steel mesh chambers implanted under the skin, and it increased collagen, protein and glycosaminoglycan content inside those chambers (Maquart, 1993). That shows an effect on wound tissue at the injection site. It does not show what an injection does to facial skin or hair.

The FDA also flags a specific safety question. It says compounded injectable drugs containing GHK-Cu may pose a risk of immunogenicity, an immune reaction, because of aggregation and peptide-related impurities (FDA). Many social media "glow" before-and-after posts also use blends that contain BPC-157 and TB-500 alongside GHK-Cu, so the result in the photo cannot be credited to GHK-Cu alone. Protocol Health offers a Glow Stack of those three peptides, so we have a commercial interest in saying this plainly.

So GHK-Cu injection results remain unproven in people, and an injection before and after photo is the weakest kind of evidence for it.

Topical vs Injection

GHK-Cu Injection vs Topical: Which Has Better Evidence?

Topical GHK-Cu has more human evidence than injectable GHK-Cu, although both are thin. The two forms share a molecule but not a research record.

QuestionTopical GHK-Cu (serum or cream)Injectable GHK-Cu (compounded)
Human evidenceSmall cosmetic studies described in reviews; one blinded randomized trial with no objective differenceNo published controlled human trial identified
Animal and lab evidenceTopical wound healing in rats and rabbitsInjection into implanted wound chambers in rats
FDA approvalNot approved as a drug; sold in cosmetic skin careNever approved by the FDA for any use
Main FDA concernNone specific to topical use on the FDA listPossible immune reaction from aggregation and impurities; limited human data
What a photo can showSurface change under matched conditionsLittle, because injected blends and other treatments are common
Sources: Pickart 2015; Miller 2006; Canapp 2003; Cangul 2006; Maquart 1993; FDA.

The topical evidence comes from the cosmetic findings summarized in the 2015 review and the blinded laser trial. The injectable record is the rat wound-chamber work and the FDA's safety note.

Bottom line: if the goal is skin appearance, topical GHK-Cu is the better-studied form, and an injection adds risk without adding published human evidence.

Does It Work

Does GHK-Cu Work?

GHK-Cu works convincingly in cells and in animal wounds, has small and mixed support on human skin, and is unproven as an injection. That is the plain answer to does GHK-Cu work.

The broader claims go further than the data. A 2018 review attributes anti-inflammatory, anti-cancer, anti-anxiety and DNA repair activity to GHK, largely from gene-expression and laboratory research. Those are leads for research, not treatments tested in people.

Testimonials do not close the gap. The FTC's rules for advertising say plainly that "consumer endorsements themselves are not competent and reliable scientific evidence" (16 CFR 255.2). A before-and-after photo is a consumer endorsement in picture form.

So GHK-Cu may help skin modestly when applied topically, but no one can promise a result, and the injectable form has not earned its reputation in trials.

Reading Photos

How to Read a GHK-Cu Before and After Photo

To read a GHK-Cu before and after photo, check whether the two images were taken the same way and whether anything besides GHK-Cu changed in between. The laser trial shows why: both groups improved, so a photo from the group without GHK-Cu would have looked just as convincing (Miller, 2006).

  • Same light, angle, distance and camera for both photos. Overhead light deepens lines; soft front light hides them.
  • The same facial expression, no makeup and no filters.
  • A stated time between photos. Skin studies measure at 12 to 24 weeks, not days.
  • Only one change. A retinoid, a laser treatment, a neurotoxin or a new routine started at the same time makes the photo uninterpretable.
  • The exact product. A blend with BPC-157 and TB-500, or a topical serum, is not the same as GHK-Cu alone.
  • Who is posting it. A seller's photo is an endorsement, not evidence.

The FTC's endorsement guides say an advertiser who cannot show that a featured result is typical should clearly disclose the performance consumers can generally expect (16 CFR 255.2). If a page shows striking photos without that context, assume they are the best cases.

So a trustworthy GHK-Cu before and after is a matched pair of photos months apart with nothing else changed, and those are rare.

New Research

What Does New GHK-Cu Research Show in 2026?

The newest GHK-Cu evidence from 2026 confirms the same pattern: strong preclinical data, very few human trials, and nothing that settles injections. A 2026 systematic review in Aesthetic Surgery Journal found 20 eligible studies, 18 of them preclinical and only 2 randomized controlled trials (Mokhtar, 2026).

That review reports that, clinically, GHK-Cu improved patient-reported satisfaction after laser resurfacing and reduced wrinkle volume and depth compared with controls. It also says the findings were constrained by methodological variability and a limited number of well-designed trials, and its abstract does not split the two trials by product form, so they should not be read as injection evidence (Mokhtar, 2026).

A second 2026 review, in Pharmaceutics, graded the clinical record as sparse. It describes the 13-participant laser study as negative on objective endpoints, and an 18-participant split-face eyebrow study as positive for cosmetic hair outcomes without defining the GHK-Cu form or local exposure (Mateescu, 2026). An eyebrow result in 18 people is not evidence of scalp hair regrowth.

So the 2026 research adds a little human data and a clearer warning: the more recent the review, the more it stresses how little is controlled.

Side Effects

What Are the Side Effects of GHK-Cu?

The side effects of GHK-Cu are not well defined in people, because no published controlled trial of injected GHK-Cu was identified and the FDA cites limited human data to inform safety (FDA). That gap is a risk in itself, and it carries the same weight as any benefit described above.

The one specific risk the FDA names for compounded injectable GHK-Cu is immunogenicity, an immune reaction linked to aggregation and peptide-related impurities (FDA). The 2026 Pharmaceutics review adds that formulation affects toxicity and that GHK-Cu products differ in chemical form, so one product's safety record does not transfer to another (Mateescu, 2026).

Online, some users describe unwanted skin changes with the slang term "copper peptide uglies." It is not a medical diagnosis, and we found no published study that defines or measures it, so treat it as anecdote, not a known side-effect rate. Our peptide therapy guide covers what to ask about any compounded peptide before starting.

So the honest answer on GHK-Cu side effects is that the risks are named by the FDA but not quantified by any trial.

Daily Injection

Is It Safe to Inject GHK-Cu Every Day?

No published study shows that injecting GHK-Cu every day is safe, and we found none that tested it. The FDA states that there are limited data in humans to inform safety-related considerations for injectable GHK-Cu (FDA). Daily schedules circulating online are not drawn from published human safety trials, so this guide does not give dosing.

Blends add uncertainty. The FDA's same page also flags compounded BPC-157 and TB-500 for possible immunogenicity (FDA), so a blend carries each ingredient's open questions. Our comparison of BPC-157 and TB-500 covers those two.

Protocol Health offers injectable GHK-Cu at its Scarsdale clinic, so we have a commercial interest in this question. It is a compounded drug that is not FDA-approved for any use, and a clinician decides whether it fits after reviewing your history.

So the safe-every-day question has no evidence-based yes, and anyone who gives a confident yes is going beyond the published data.

Our Approach

GHK-Cu at Protocol Health

At Protocol Health, GHK-Cu is considered only after a physician consultation about your skin or hair goals, your history and, where relevant, lab work to look for other causes of the change you are noticing. Your provider explains the topical and injectable evidence separately and may recommend GHK-Cu, a different approach, or nothing at all.

We offer GHK-Cu and the Glow Stack, so we have a commercial interest in this topic, which is why this guide reports the null blinded result alongside the positive ones. GHK-Cu is offered in person at our Scarsdale clinic only, not by telehealth, and no result is guaranteed.

Read about GHK-Cu copper peptide therapy or take the Protocol Health quiz to start a consultation. This guide is educational and is not medical advice; the decision about GHK-Cu belongs with a licensed provider who knows your history. For the basics of the molecule, see what GHK-Cu is.

Bottom Line

The Bottom Line

A realistic GHK-Cu before and after is a slow, modest change at best.

  • Judge results over months. Topical anti-aging trials run 12 to 24 weeks (Kafi et al., 2007).
  • Photos are weak evidence. Endorsements are not competent scientific evidence (16 CFR 255.2).
  • Topical beats injection on evidence. Injection adds risk without published human results.
  • Hair claims are unproven. The evidence is follicle and cell work.
  • At Protocol Health, GHK-Cu is clinic-only. It is not offered by telehealth.

FAQ

Frequently Asked Questions

How long does it take for GHK-Cu to work?

No human trial has tracked GHK-Cu week by week. The one blinded human skin trial assessed results at 12 weeks, and comparable topical anti-aging trials run 12 to 24 weeks, so judge any change over about three months or more.

Is GHK-Cu FDA approved?

No. GHK-Cu is not approved by the FDA for any use. Copper peptides are sold in cosmetic skin care, and an injectable form is a compounded, unapproved drug that the FDA says carries a possible risk of immune reactions.

Is GHK-Cu legal?

Topical copper peptide skin care is legal to buy. An injection is legal only as a compounded drug prescribed by a licensed clinician. Vials sold as research peptides or not for human use have no assurance of purity or sterility.

Do GHK-Cu before and after photos prove it works?

No. In a blinded trial, patients using GHK-Cu rated their skin better, but blinded evaluators found no objective difference. Photos also vary with light, angle and other treatments.

Is topical GHK-Cu better than injections?

For skin appearance, topical GHK-Cu has more human evidence than injections, though it is still small. No published controlled human trial of injected GHK-Cu was identified.

Can GHK-Cu results show up in a week?

Visible collagen change in a week is unlikely, since topical skin trials measure results at 12 to 24 weeks. A change in a one-week photo is more likely to reflect lighting, angle or other products.

Is it safe to inject GHK-Cu every day?

No published study shows that daily GHK-Cu injection is safe. The FDA states there are limited human data to inform safety and flags a possible immune reaction (immunogenicity) for compounded injectable GHK-Cu.

What are the side effects of GHK-Cu?

They are not well defined. No controlled human trial of injected GHK-Cu was identified, and the FDA names possible immunogenicity from aggregation and impurities. The slang term "copper peptide uglies" has no published definition.

Explore

Related at Protocol Health

Talk to a provider about GHK-Cu

Medical disclaimer

This article is for education only and is not medical advice, diagnosis, or treatment. Talk to a licensed clinician before starting, stopping, or changing any medication.

Important safety information

References

  1. Maquart FX et al., 1988. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. PMID 3169264. https://pubmed.ncbi.nlm.nih.gov/3169264/
  2. Miller TR et al., 2006. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. PMID 16847171. https://pubmed.ncbi.nlm.nih.gov/16847171/
  3. Pickart L et al., 2015. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. PMID 26236730. https://pubmed.ncbi.nlm.nih.gov/26236730/
  4. US Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
  5. Maquart FX et al., 1993. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest. PMID 8227353. https://pubmed.ncbi.nlm.nih.gov/8227353/
  6. Canapp SO Jr et al., 2003. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Vet Surg. PMID 14648529. https://pubmed.ncbi.nlm.nih.gov/14648529/
  7. Kafi R et al., 2007. Improvement of naturally aged skin with vitamin A (retinol). Arch Dermatol. PMID 17515510. https://pubmed.ncbi.nlm.nih.gov/17515510/
  8. Cangul IT et al., 2006. Evaluation of the effects of topical tripeptide-copper complex and zinc oxide on open-wound healing in rabbits. Vet Dermatol. PMID 17083573. https://pubmed.ncbi.nlm.nih.gov/17083573/
  9. Pickart L, 2008. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. PMID 18644225. https://pubmed.ncbi.nlm.nih.gov/18644225/
  10. Pollard JD et al., 2005. Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts. Arch Facial Plast Surg. PMID 15655171. https://pubmed.ncbi.nlm.nih.gov/15655171/
Show all 15 references
  1. Pyo HK et al., 2007. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. PMID 17703734. https://pubmed.ncbi.nlm.nih.gov/17703734/
  2. Pickart L et al., 2018. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. PMID 29986520. https://pubmed.ncbi.nlm.nih.gov/29986520/
  3. 16 CFR 255.2. Consumer endorsements. Electronic Code of Federal Regulations. https://www.ecfr.gov/current/title-16/chapter-I/subchapter-B/part-255/section-255.2
  4. Mokhtar J et al., 2026. The Regenerative Potential of GHK-Cu in Aesthetic Medicine. Aesthet Surg J. PMID 42619529. https://pubmed.ncbi.nlm.nih.gov/42619529/
  5. Mateescu DM et al., 2026. GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo. Pharmaceutics. PMID 42797253. https://pubmed.ncbi.nlm.nih.gov/42797253/

Why trust our physicians

Every article is reviewed by a licensed physician on our medical team and is kept current by our editorial team. Read our editorial policy and our medical review process.

Medically reviewed by
Richard Dentico, MD on
Written by
Protocol Health Editorial Team
First published
Last updated

See an error? Email care@protocolhealthmd.com and we will review it.

More on GHK-Cu & Skin Peptides

All Peptides articles →